Select Bibliography

Filter by any of these (after searching):

N08CB

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 10 items

Genetic Predictors of Chemotherapy-Induced Peripheral Neuropathy from Paclitaxel, Carboplatin and Oxaliplatin: NCCTG/Alliance N08C1, N08CA and N08CB Study

Adjei, Araba A. , Lopez, Camden L. , Schaid, Daniel J. ... - - Cancers (Basel) - 2021

Manuscript - Secondary-not-in-original - Primary - Symptom Inter - N08C1 , N08CA , N08CB

Patient-Reported (EORTC QLQ-CIPN20) Versus Physician-Reported (CTCAE) Quantification of Oxaliplatin- and Paclitaxel/Carboplatin-Induced Peripheral Neuropathy in NCCTG/Alliance Clinical Trials

Le-Rademacher, Jennifer , Kanwar, Rahul , Seisler, Drew ... - - Support Care Cancer - 2017

Manuscript - Secondary-not-in-original - Meta-Analysis - Symptom Inter - N08CA , N08CB

Phase III randomized, placebo (PL)-controlled, double-blind study of intravenous calcium/magnesium (CaMg) to prevent oxaliplatin-induced sensory neurotoxicity (sNT), N08CB: An Alliance for Clinical Trials in Oncology study

Loprinzi, C. L. , Qin, R. , Dakhil, S. R. , Fehrenbacher, L. ... - - J. Clin. Oncol. - 2013

Abstract - Primary - Primary - Symptom Inter - N08CB

Phase III Randomized, Placebo-Controlled, Double-Blind Study of Intravenous Calcium and Magnesium to Prevent Oxaliplatin-Induced Sensory Neurotoxicity (N08CB/Alliance)

Loprinzi, Charles L. , Qin, Rui , Dakhil, Shaker R. ... - - J. Clin. Oncol - 2014

Manuscript - Primary - Primary - Symptom Inter - N08CB

Clinical course of patients with oxaliplatin-associated neuropathy: N08CB (Alliance)

Pachman, Deirdre R. , Qin, Rui , Seisler, Drew K. ... - ASCO - J. Clin. Oncol. - 2014

Abstract - Secondary - Primary - Symptom Inter - N08CB

Clinical Course of Oxaliplatin-Induced Neuropathy: Results From the Randomized Phase III Trial N08CB (Alliance)

Pachman, Deirdre R. , Qin, Rui , Seisler, Drew K. , Smith, Ellen M.L. ... - - J. Clin. Oncol - 2015

Manuscript - Secondary - Primary - Symptom Inter - N08CB

Comparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505)

Pachman, Deirdre R. , Qin, Rui , Seisler, Drew ... - - Support Care Cancer - 2016

Manuscript - Primary - Primary - Symptom Inter - A151505 , N08C1 , N08CB

A Comparison of the Natural History of Oxaliplatin- and Paclitaxel-Induced Neuropathy (NCCTG N08C1, N08CB/Alliance)

Ruddy, Kathryn Jean , Pachman, Dierdre , Qin, Rui , Seisler, Drew K. ... - ASCO - J. Clin. Oncol. - 2015

Abstract - Primary - Primary - Symptom Inter - A151505 , N08C1 , N08CB

The reliability, validity, and sensitivity of the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire-chemotherapy-induced Peripheral Neuropathy (QLQ-CIPN-20).

Smith, E. M. L. , Yang , J. , Banerjee, T. , Loprinizi, C. ... - MNRS - - 2016

Abstract - Secondary-not-in-original - Meta-Analysis - Symptom Inter - N06CA , CI-PeriNomS , N08C1 , N08CA , N08CB

Rasch model-based testing of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire–Chemotherapy-Induced Peripheral Neuropathy (QLQ-CIPN20) using Alliance for Clinical Trials in Oncology (Alliance) A151408 study data

Smith, Ellen M. Lavoie , Zanville, Noah , Kanzawa-Lee, Grace ... - - Support Care Cancer - 2019

Manuscript - Primary - Primary - Symptom Inter - A151408 , N06CA , N08C1 , N08CA , N08CB